Table 1 Participant characteristics
Participant category | Gender | Race | Plasma viral load, RNA copies ml−1a (median) | CD4 count, cells mm −3 (median) | Time post HIV + diagnosis (years) (median) |
|---|---|---|---|---|---|
HIV controllers (n=11) | M6, F3, T2 | AA7, C3, Mx1 | <40 | 746 | 20.2 |
Viremic untreated (n=16) | M15 | AA7, C6, L2 | 20,544 | 421 | 10.8 |
Early infection (n=6) | M6 | AA2, C4 | 97,107 | 460 | 0.21 |
ART treated (n=23) | M20, F1, T2 | AA5, C13, L3, Mx2 | <40 | 598 | 16.5 |
HIV seronegativesb (n=19) | M16, F1, T1 | AA5, C10, L1, Mx1, NAm1 | NA | 975 | NA |